"For more than two decades Aaron has earned the trust of life science leaders for his deep expertise in the industry and delivering for his clients," said Curtis Lane, Founding Partner of MTS. "We are ...

Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

AstraZeneca PLC AZN shares dropped 1.66% to £115.84 Monday, on what proved to be an all-around great trading session for the ...

Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...

A cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping patients live longer ...

For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the ...

Forbes recently listed the best employers in the U.S. and in each state for 2024, with 15 Delaware employers included. Find out how they fared.

A new dose-finding study supported the potential of the carbonic anhydrase inhibitor as an alternative to CPAP machines.

Nevada U.S. Senator Jacky Rosen, Colleagues File Amicus Brief Urging Court to Uphold Medicare’s Ability to Negotiate Lower ...

Biohaven's drug for a genetic disease that affects the nervous system met the main study goal, sending its shares up more ...

This summary covers the latest in health news including AstraZeneca's breast cancer drug trial disappointing, Biohaven ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second quarter 2024 ...